These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33392841)

  • 21. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
    Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
    Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas.
    Risch A; Wikman H; Thiel S; Schmezer P; Edler L; Drings P; Dienemann H; Kayser K; Schulz V; Spiegelhalder B; Bartsch H
    Pharmacogenetics; 2001 Dec; 11(9):757-64. PubMed ID: 11740339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer.
    Helzlsouer KJ; Selmin O; Huang HY; Strickland PT; Hoffman S; Alberg AJ; Watson M; Comstock GW; Bell D
    J Natl Cancer Inst; 1998 Apr; 90(7):512-8. PubMed ID: 9539246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphism of xenobiotic-metabolizing genes and breast cancer susceptibility in North Indian women.
    Singh V; Upadhyay G; Rastogi N; Singh K; Singh MP
    Genet Test Mol Biomarkers; 2011 May; 15(5):343-9. PubMed ID: 21329464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the GSTM1 null polymorphism with breast cancer in a Mexican population.
    Soto-Quintana O; Zúñiga-González GM; Ramírez-Patiño R; Ramos-Silva A; Figuera LE; Carrillo-Moreno DI; Gutiérrez-Hurtado IA; Puebla-Pérez AM; Sánchez-Llamas B; Gallegos-Arreola MP
    Genet Mol Res; 2015 Oct; 14(4):13066-75. PubMed ID: 26535619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of glutathione-S-transferase M1, T1, P1 and the risk of prostate cancer: a case-control study.
    Sivonová M; Waczulíková I; Dobrota D; Matáková T; Hatok J; Racay P; Kliment J
    J Exp Clin Cancer Res; 2009 Mar; 28(1):32. PubMed ID: 19265530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
    Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
    Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between GSTM1, GSTT1, and GSTP1 variants and the risk of end stage renal disease.
    Nomani H; Hagh-Nazari L; Aidy A; Vaisi-Raygani A; Kiani A; Rahimi Z; Bahrehmand F; Shakiba E; Mozaffari HR; Tavilani H; Pourmotabbed T
    Ren Fail; 2016 Oct; 38(9):1455-1461. PubMed ID: 27498857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between glutathione S-transferase M1 and T1 gene polymorphisms and susceptibility to preeclampsia: An updated systematic review and meta-analysis.
    Sljivancanin Jakovljevic T; Jacimovic J; Nikolic N; Milasin J
    Am J Reprod Immunol; 2020 Dec; 84(6):e13303. PubMed ID: 32658338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione S-transferase M1, T1, and P1 genotypes and breast cancer risk: a study in a Portuguese population.
    Ramalhinho AC; Fonseca-Moutinho JA; Breitenfeld L
    Mol Cell Biochem; 2011 Sep; 355(1-2):265-71. PubMed ID: 21559761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers.
    Reszka E; Czekaj P; Adamska J; Wasowicz W
    Clin Chem Lab Med; 2008; 46(8):1090-6. PubMed ID: 18590468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between glutathione S-transferase M1, T1 genotype and susceptibility to gastric cancer].
    Cai L; Yu S; Chen J
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):331-3. PubMed ID: 11864501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma.
    Casson AG; Zheng Z; Chiasson D; MacDonald K; Riddell DC; Guernsey JR; Guernsey DL; McLaughlin J
    Cancer Detect Prev; 2003; 27(2):139-46. PubMed ID: 12670526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutathione S-transferase T1, M1 and P1 Genetic Polymorphisms and Susceptibility to Colorectal Cancer in Turkey.
    Gorukmez O; Yakut T; Gorukmez O; Sag SO; Topak A; Sahinturk S; Kanat O
    Asian Pac J Cancer Prev; 2016; 17(8):3855-9. PubMed ID: 27644629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of glutathione S-transferase T1, M1 and P1 genotypes and breast cancer risk.
    Unlü A; Ates NA; Tamer L; Ates C
    Cell Biochem Funct; 2008; 26(5):643-7. PubMed ID: 18521819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the GST-T1 and GST-M1 null genotypes using high resolution melting analysis.
    Drobná Z; Del Razo LM; Garcia-Vargas G; Sánchez-Ramírez B; González-Horta C; Ballinas-Casarrubias L; Loomis D; Stýblo M
    Chem Res Toxicol; 2012 Jan; 25(1):216-24. PubMed ID: 22136492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia.
    Rollinson S; Roddam P; Kane E; Roman E; Cartwright R; Jack A; Morgan GJ
    Carcinogenesis; 2000 Jan; 21(1):43-7. PubMed ID: 10607732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case control study on the impact of CYP450 MSPI and GST-M1 polymorphisms on the risk of lung cancer].
    Wang BG; Chen SD; Zhou WP; Zeng M; Li ZB; Cai XL; Wang DQ
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):93-7. PubMed ID: 15059326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions.
    Krajinovic M; Ghadirian P; Richer C; Sinnett H; Gandini S; Perret C; Lacroix A; Labuda D; Sinnett D
    Int J Cancer; 2001 Apr; 92(2):220-5. PubMed ID: 11291049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Polymorphism of Xenobiotic Biotransformation Enzymes in Patients with Classical Ph-Negative Myeloproliferative Neoplasms.
    Ovsepyan VA; Tregubova EV; Luchinin AS; Minaeva NV
    Bull Exp Biol Med; 2019 Oct; 167(6):767-770. PubMed ID: 31677022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.